Your browser doesn't support javascript.
loading
TRPA1 ankyrin repeat six interacts with a small molecule inhibitor chemotype.
Tseng, Wei Chou; Pryde, David C; Yoger, Katrina E; Padilla, Karen M; Antonio, Brett M; Han, Seungil; Shanmugasundaram, Veerabahu; Gerlach, Aaron C.
Affiliation
  • Tseng WC; Internal Medicine Research Unit, Pfizer, Cambridge, MA 02139.
  • Pryde DC; Worldwide Medicinal Chemistry, Pfizer, Great Abington, CB21 6GS Cambridgeshire, United Kingdom.
  • Yoger KE; Icagen Inc., Durham, NC 27703.
  • Padilla KM; Icagen Inc., Durham, NC 27703.
  • Antonio BM; Icagen Inc., Durham, NC 27703.
  • Han S; Worldwide Research & Development, Pfizer, Groton, CT 06340.
  • Shanmugasundaram V; Worldwide Research & Development, Pfizer, Groton, CT 06340.
  • Gerlach AC; Icagen Inc., Durham, NC 27703; agerlach@icagen.com.
Proc Natl Acad Sci U S A ; 115(48): 12301-12306, 2018 11 27.
Article in En | MEDLINE | ID: mdl-30429323
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Small Molecule Libraries / TRPA1 Cation Channel Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Small Molecule Libraries / TRPA1 Cation Channel Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2018 Type: Article